These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 21271404)

  • 1. Correlates of poor perceived health among individuals living with HIV and HBV chronic infections: a longitudinal assessment.
    Marcellin F; Lacombe K; Fugon L; Molina JM; Bonnard P; Miailhes P; Lascoux-Combe C; Roux P; Carrieri MP; Girard PM; Spire B
    AIDS Care; 2011 Apr; 23(4):501-7. PubMed ID: 21271404
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Longitudinal evaluation of viral interactions in treated HIV-hepatitis B co-infected patients with additional hepatitis C and D virus.
    Boyd A; Lacombe K; Miailhes P; Gozlan J; Bonnard P; Molina JM; Lascoux-Combe C; Serfaty L; Gault E; Desvarieux M; Girard PM
    J Viral Hepat; 2010 Jan; 17(1):65-76. PubMed ID: 19682317
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of hepatitis B virus co-infection on response to highly active antiretroviral treatment and outcome in HIV-infected individuals: a nationwide cohort study.
    Omland LH; Weis N; Skinhøj P; Laursen A; Christensen PB; Nielsen HI; Møller A; Engsig F; Sørensen HT; Obel N
    HIV Med; 2008 May; 9(5):300-6. PubMed ID: 18400077
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predictors of hepatitis B virus genotype and viraemia in HIV-infected patients with chronic hepatitis B in Europe.
    Soriano V; Mocroft A; Peters L; Rockstroh J; Antunes F; Kirkby N; de Wit S; Monforte Ad; Flisiak R; Lundgren J;
    J Antimicrob Chemother; 2010 Mar; 65(3):548-55. PubMed ID: 20051475
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Chronic hepatitis B and C in HIV-infected patients].
    Opravil M; Hunziker R; Lüthy R; Grob PJ
    Dtsch Med Wochenschr; 1998 Jun; 123(24):753-60. PubMed ID: 9672477
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Patients co-infected with HIV and hepatitis-B virus (HBV): the favourable effect of lamivudine, as part of combined antiretroviral therapy, on HBV may be dependent upon the number of CD4-cells].
    Smit MC; Haverkamp MH; Weersink AJ; Boucher CA; Hoepelman IM
    Ned Tijdschr Geneeskd; 2004 Nov; 148(47):2330-4. PubMed ID: 15587052
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of hepatitis D virus infection on the long-term outcomes of patients with hepatitis B virus and HIV coinfection in the era of highly active antiretroviral therapy: a matched cohort study.
    Sheng WH; Hung CC; Kao JH; Chang SY; Chen MY; Hsieh SM; Chen PJ; Chang SC
    Clin Infect Dis; 2007 Apr; 44(7):988-95. PubMed ID: 17342655
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chronic hepatitis B and other correlates of spontaneous clearance of hepatitis C virus among HIV-infected people with hemophilia.
    Melendez-Morales L; Konkle BA; Preiss L; Zhang M; Mathew P; Eyster ME; Goedert JJ
    AIDS; 2007 Jul; 21(12):1631-6. PubMed ID: 17630559
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multiple viral infections.
    Gaeta GB; Precone DF; Cozzi-Lepri A; Cicconi P; D'Arminio Monforte A
    J Hepatol; 2006; 44(1 Suppl):S108-13. PubMed ID: 16352369
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of a novel hepatitis B virus precore/core deletion mutant in HIV/hepatitis B virus co-infected individuals.
    Revill PA; Littlejohn M; Ayres A; Yuen L; Colledge D; Bartholomeusz A; Sasaduesz J; Lewin SR; Dore GJ; Matthews GV; Thio CL; Locarnini SA
    AIDS; 2007 Aug; 21(13):1701-10. PubMed ID: 17690567
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antiretroviral treatment change among HIV, hepatitis B virus and hepatitis C virus co-infected patients in the Australian HIV Observational Database.
    Petoumenos K; Ringland C;
    HIV Med; 2005 May; 6(3):155-63. PubMed ID: 15876281
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatitis B, C seroprevalence and delta viruses in HIV-1 Senegalese patients at HAART initiation (retrospective study).
    Diop-Ndiaye H; Touré-Kane C; Etard JF; Lô G; Diaw P; Ngom-Gueye NF; Gueye PM; Ba-Fall K; Ndiaye I; Sow PS; Delaporte E; Mboup S
    J Med Virol; 2008 Aug; 80(8):1332-6. PubMed ID: 18551596
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of highly active antiretroviral therapy (HAART) on the natural history of hepatitis B virus (HBV) and HIV coinfection: relationship between prolonged efficacy of HAART and HBV surface and early antigen seroconversion.
    Miailhes P; Trabaud MA; Pradat P; Lebouché B; Chevallier M; Chevallier P; Zoulim F; Trepo C
    Clin Infect Dis; 2007 Sep; 45(5):624-32. PubMed ID: 17682999
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of chronic hepatitis B in HIV co-infected patients.
    Guan R
    Med J Malaysia; 2005 Jul; 60 Suppl B():52-6. PubMed ID: 16108174
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact and management of hepatitis B and hepatitis C virus co-infection in HIV patients.
    Kumar R; Singla V; Kacharya Sk
    Trop Gastroenterol; 2008; 29(3):136-47. PubMed ID: 19115605
    [TBL] [Abstract][Full Text] [Related]  

  • 16. European AIDS Clinical Society (EACS) guidelines for the clinical management and treatment of chronic hepatitis B and C coinfection in HIV-infected adults.
    Rockstroh JK; Bhagani S; Benhamou Y; Bruno R; Mauss S; Peters L; Puoti M; Soriano V; Tural C;
    HIV Med; 2008 Feb; 9(2):82-8. PubMed ID: 18257771
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epidemiology, diagnosis and treatment of chronic hepatitis B in HIV-infected patients (EPIB 2005 STUDY).
    Piroth L; Sène D; Pol S; Goderel I; Lacombe K; Martha B; Rey D; Loustau-Ratti V; Bergmann JF; Pialoux G; Gervais A; Lascoux-Combe C; Carrat F; Cacoub P
    AIDS; 2007 Jun; 21(10):1323-31. PubMed ID: 17545709
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of tenofovir-containing antiretroviral therapy on chronic hepatitis B in a cohort co-infected with human immunodeficiency virus.
    Stephan C; Berger A; Carlebach A; Lutz T; Bickel M; Klauke S; Staszewski S; Stuermer M
    J Antimicrob Chemother; 2005 Dec; 56(6):1087-93. PubMed ID: 16269552
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of hepatitis C infection on progression of HIV disease and early response to initial antiretroviral therapy.
    Sullivan PS; Hanson DL; Teshale EH; Wotring LL; Brooks JT
    AIDS; 2006 May; 20(8):1171-9. PubMed ID: 16691069
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of viral hepatitis on HIV infection.
    Rockstroh JK
    J Hepatol; 2006; 44(1 Suppl):S25-7. PubMed ID: 16338020
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.